Literature DB >> 23629860

Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.

K Alexa Orr Gandy1, Mohamad Adada, Daniel Canals, Brittany Carroll, Patrick Roddy, Yusuf A Hannun, Lina M Obeid.   

Abstract

Ezrin, radixin, and moesin (ERM) proteins link cortical actin to the plasma membrane and coordinate cellular events that require cytoskeletal rearrangement, including cell division, migration, and invasion. While ERM proteins are involved in many important cellular events, the mechanisms regulating their function are not completely understood. Our laboratory previously identified reciprocal roles for the sphingolipids ceramide and sphingosine-1-phosphate (S1P) in the regulation of ERM proteins. We recently showed that ceramide-induced activation of PP1α leads to dephosphorylation and inactivation of ERM proteins, while S1P results in phosphorylation and activation of ERM proteins. Following these findings, we aimed to examine known inducers of the SK/S1P pathway and evaluate their ability to regulate ERM proteins. We examined EGF, a known inducer of the SK/S1P pathway, for its ability to regulate the ERM family of proteins. We found that EGF induces ERM c-terminal threonine phosphorylation via activation of the SK/S1P pathway, as this was prevented by siRNA knockdown or pharmacological inhibition of SK. Using pharmacological, as well as genetic, knockdown approaches, we determined that EGF induces ERM phosphorylation via activation of S1PR2. In addition, EGF led to cell polarization in the form of lamellipodia, and this occurred through a mechanism involving S1PR2-mediated phosphorylation of ezrin T567. EGF-induced cellular invasion was also found to be dependent on S1PR2-induced T567 ezrin phosphorylation, such that S1PR2 antagonist, JTE-013, and expression of a dominant-negative ezrin mutant prevented cellular invasion toward EGF. In this work, a novel mechanism of EGF-stimulated invasion is unveiled, whereby S1P-mediated activation of S1PR2 and phosphorylation of ezrin T567 is required.

Entities:  

Keywords:  actin cytoskeleton; moesin; polarization; radixin

Mesh:

Substances:

Year:  2013        PMID: 23629860      PMCID: PMC3714586          DOI: 10.1096/fj.13-228460

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  64 in total

1.  beta4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1.

Authors:  Christine E Pullar; Brian S Baier; Yoshinobu Kariya; Alan J Russell; Basil A J Horst; M Peter Marinkovich; R Rivkah Isseroff
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

2.  PP1-mediated moesin dephosphorylation couples polar relaxation to mitotic exit.

Authors:  Patricia Kunda; Nelio T L Rodrigues; Emadaldin Moeendarbary; Tao Liu; Aleksandar Ivetic; Guillaume Charras; Buzz Baum
Journal:  Curr Biol       Date:  2011-12-29       Impact factor: 10.834

3.  Sphingosine kinases regulate NOX2 activity via p38 MAPK-dependent translocation of S100A8/A9.

Authors:  Véronique Schenten; Chantal Melchior; Natacha Steinckwich; Eric J Tschirhart; Sabrina Bréchard
Journal:  J Leukoc Biol       Date:  2011-01-13       Impact factor: 4.962

4.  Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate.

Authors:  Yugesh Kharel; Thomas P Mathews; Amanda M Gellett; Jose L Tomsig; Perry C Kennedy; Morgan L Moyer; Timothy L Macdonald; Kevin R Lynch
Journal:  Biochem J       Date:  2011-12-15       Impact factor: 3.857

Review 5.  Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer.

Authors:  Marta Batus; Mary Jo Fidler; Philip D Bonomi
Journal:  Expert Rev Anticancer Ther       Date:  2010-10       Impact factor: 4.512

6.  Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta.

Authors:  James Van Brocklyn; Catherine Letterle; Pamela Snyder; Thomas Prior
Journal:  Cancer Lett       Date:  2002-07-26       Impact factor: 8.679

7.  Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells.

Authors:  Hironori Yamaguchi; Joji Kitayama; Noriko Takuwa; Kayo Arikawa; Isao Inoki; Kazuhiko Takehara; Hirokazu Nagawa; Yoh Takuwa
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

8.  Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2.

Authors:  Viviana Anelli; Christopher R Gault; Amy B Cheng; Lina M Obeid
Journal:  J Biol Chem       Date:  2007-11-30       Impact factor: 5.157

9.  The protein-tyrosine kinase substrate, p81, is homologous to a chicken microvillar core protein.

Authors:  K L Gould; J A Cooper; A Bretscher; T Hunter
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

10.  Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway.

Authors:  Youssef H Zeidan; Russell W Jenkins; Yusuf A Hannun
Journal:  J Cell Biol       Date:  2008-04-21       Impact factor: 10.539

View more
  18 in total

1.  Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma.

Authors:  Mei-Hong Li; Rolf Swenson; Miriam Harel; Sampa Jana; Erik Stolarzewicz; Timothy Hla; Linda H Shapiro; Fernando Ferrer
Journal:  J Pharmacol Exp Ther       Date:  2015-06-23       Impact factor: 4.030

2.  Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase.

Authors:  Anja Schwiebs; Martina Herrero San Juan; Katrin G Schmidt; Eliza Wiercinska; Martin Anlauf; Florian Ottenlinger; Dominique Thomas; Eiman Elwakeel; Andreas Weigert; Henner F Farin; Halvard Bonig; Klaus Scholich; Gerd Geisslinger; Josef M Pfeilschifter; Heinfried H Radeke
Journal:  Oncogene       Date:  2019-02-28       Impact factor: 9.867

Review 3.  Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2013-07-12

4.  A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.

Authors:  Mohamed F Salama; Brittany Carroll; Mohamad Adada; Michael Pulkoski-Gross; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2015-03-24       Impact factor: 5.191

5.  Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion.

Authors:  Mohamad M Adada; Daniel Canals; Nara Jeong; Ashwin D Kelkar; Maria Hernandez-Corbacho; Michael J Pulkoski-Gross; Jane C Donaldson; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2015-07-24       Impact factor: 5.191

6.  Ezrin expression and cell survival regulation in colorectal cancer.

Authors:  Premila D Leiphrakpam; Ashwani Rajput; Michelle Mathiesen; Ekta Agarwal; Audrey J Lazenby; Chandrakanth Are; Michael G Brattain; Sanjib Chowdhury
Journal:  Cell Signal       Date:  2014-01-22       Impact factor: 4.315

7.  Sphingosine 1-phosphate activation of ERM contributes to vascular calcification.

Authors:  Thomas G Morris; Samantha J Borland; Christopher J Clarke; Claire Wilson; Yusuf A Hannun; Vasken Ohanian; Ann E Canfield; Jacqueline Ohanian
Journal:  J Lipid Res       Date:  2017-11-22       Impact factor: 5.922

Review 8.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

9.  The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alpha.

Authors:  Daniel Canals; Silvia Salamone; Bruno Jaime Santacreu; Daniel Aguilar; María José Hernandez-Corbacho; Anne G Ostermeyer-Fay; Meaghan Greene; Erika Nemeth; John D Haley; Lina M Obeid; Yusuf A Hannun
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.191

10.  Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer.

Authors:  Tiefeng Jin; Jingchun Jin; Xiangyu Li; Songnan Zhang; Yun Ho Choi; Yingshi Piao; Xionghu Shen; Zhenhua Lin
Journal:  BMC Cancer       Date:  2014-03-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.